Konsultatsioonid
Closed consultations
-
10 - 19 Märts 2021
-
25 November 2020 - 06 Jaanuar 2021
Based on the outcome of the evaluation of the medicines for rare diseases and children legislation, the Commission will examine the impacts of future policy options to update the legal framework on medicines for rare diseases and paediatric medicines. The first step is an inception impact assessment (roadmap).
The revision of the two legislations is also one of the actions of the EU Pharmaceutical Strategy.
-
22 Juuni - 22 Juuli 2020
-
16 Juuni - 15 September 2020
-
02 Juuni - 07 Juuli 2020
-
20 Märts - 20 Juuni 2020
-
20 Veebruar - 20 Mai 2020
-
29 Jaanuar - 28 Aprill 2019
-
18 Oktoober 2018 - 04 Jaanuar 2019
-
01 August - 31 Oktoober 2018